Results 101 to 110 of about 19,015 (258)
Biological and clinical aspects of ABO blood group system
The ABO blood group was discovered in 1900 by Austrian scientist, Karl Landsteiner. At present, the International Society of Blood Transfusion (ISBT) approves as 29 human blood group systems. The ABO blood group system consists of four antigens (A, B, O and AB). These antigens are known as oligosaccharide antigens, and widely expressed on the membranes
openaire +3 more sources
Deceased donor ABO discrepancy due to a rare AwB subgroup: Implications for organ allocation
Abstract Background Accurate ABO determination is critical for safe deceased donor organ allocation. Weak or variant ABO subgroups may not be reliably detected by routine serologic testing, especially under urgent conditions or following transfusion. Such limitations can result in discrepant ABO assignments with potential implications for transplant ...
Sara O. Dionne +3 more
wiley +1 more source
Genetic analysis of cases from a family with reduced B antigen expression in ABO blood group system
[Objective] To classify the ABO blood group phenotypes of 5 cases from a family, and to explore the molecular mechanism for reduced B antigen expression in ABO blood group system.
ZHOU Taimei +5 more
doaj +1 more source
Revealing and quantifying polyclonal anti‐A, B specificity in ABO histo‐blood groups
Abstract Background The clinically significant antibody anti‐A,B together with anti‐A and anti‐B has been known for many decades to be present in blood group O plasma. As anti‐A,B is only reactive when an A or B antigen is present, its contribution to titer cannot be easily distinguished from anti‐A and/or anti‐B.
Stephen Henry +6 more
wiley +1 more source
Abstract Background and Objectives The European Union's ban on the use of di(2‐ethylhexyl) phthalate (DEHP) in medical devices will take effect in 2030. DEHP is a plasticizer in polyvinyl chloride blood bags that helps stabilize the red blood cell membrane during hypothermic red blood cell concentrate (RBCC) storage.
Sandra Ramirez‐Arcos +8 more
wiley +1 more source
Abstract Background and Objectives Adequate representation of donors from diverse ancestral populations in blood, stem cell and organ transplantation is critical to ensuring equitable access to these lifesaving therapies. Because of population‐level differences in genetic markers, patients from racialized groups may have unique transfusion and ...
Bonnie Lu +9 more
wiley +1 more source
Abstract Background and Objectives Hypoxic/hypocapnic (HH) treatment and storage conditions have been shown to reduce oxidative stress and improve red blood cell (RBC) quality. This study aimed to validate a good manufacturing practice HH RBC product for obtaining the licence for routine use in patients, by comparison with normoxic RBCs both without ...
Soroth Chey +3 more
wiley +1 more source
Objective Here, we sought to report ABO and D antigen distribution in blood donors from Yogyakarta, Java Island, Indonesia. Phenotype data (ABO/D) from donors who donated blood between January 1, 2018, and December 31, 2023, at the Yogyakarta Blood Donor
Hasna Fadlilatul Bidayah +5 more
doaj +1 more source
Fundamentals of big data and artificial intelligence in transfusion medicine
Abstract Within the digital transformation of medicine, transfusion medicine has quietly become a big‐data discipline. The long‐standing tradition of blood product standardization (e.g., ISBT‐128) and large donor cohorts being followed over years—some of which are sampled in national biobank projects, build a favourable setting.
Amin T. Turki +10 more
wiley +1 more source
Summary. Role of blood factors as probable genetic markers investigated tooth decay in 93 people aged 12-14 years. Representation material found on comparative assessment of the frequency of detection of blood groups in 3227 blood donors - residents of ...
V. Revich, T. Shuminska
doaj

